Artemis Pharmaceuticals GMBH
This article was originally published in Start Up
Executive Summary
Artemis's scientific co-founder, Christiane Nusslein-Volhard, PhD, of the Max Planck Institute, is one of the world's experts and the pioneer in the genetic study of zebra fish. Nusslein-Volhard, who retains her academic position, brings this expertise to Artemis, which is putting a commercial spin on the research. The start-up is knocking out genes in the fish and relating mutations to diseases seen in other vertebrates.